CSI Singapore
NUS Researchers Identify Novel Pathways Responsible For Liver Cancer
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It is one of leading causes of cancer-related deaths globally, with more than 700,000 new cases and 600,000 estimated HCC deaths each year. HCC occurs most often in people with chronic liver diseases such as hepatitis B, which is one of the main …
NUS Researchers Use “Automated” Microscopy To Identify Predictor Of Chemotherapy Resistance In Ovarian Cancer Patients
Epithelial ovarian cancer (EOC) is the most common lethal gynaecological cancer. Ovarian cancer is usually treated with platinum-based chemotherapy; however, a significant number of patients are resistant to such treatments and relapse soon afterwards. To improve their survival, there is a need to first identify which patients may be platinum-resistant, so that newer treatments may …
New NUS Research Breakthrough: CircASXL1-1 Regulates BAP1 Deubiquitinase Activity In Leukemia
In Singapore, there are over 2,000 new cases of blood cancers diagnosed every year. While Singapore boasts one of the highest cure rates for acute leukemia in children, the cure rate for middle-aged adults hovers around only 50 percent. Presently, chemotherapy remains the most common and effective course of treatment. However, the emergence of more …